First synthesis of a malarial prototype: A fully lipidated and phosphorylated GPI membrane anchor

Tetrahedron Letters

Volumn 45, Issue 4, 2004, Pages 879-882

  Lu, Jun ^a   Jayaprakash, K N ^a   Fraser Reid, Bert ^a  

^a Nat Prod Glycotechnology Res I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA METHYLGLUCOSIDE; ESTER; GLYCOSYLPHOSPHATIDYLINOSITOL; INOSITOL; LIPID; MANNOSE; PENTASACCHARIDE; PHOSPHATIDYLINOSITIDE;

ARTICLE; BIOSYNTHESIS; BRAIN MALARIA; CHEMICAL PROCEDURES; DRUG SYNTHESIS; LETHALITY; MATERIALS; MEMBRANE; NONHUMAN; PHOSPHORYLATION; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 0346157341     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.10.179     Document Type: Article

References (42)

1. For a brief introduction, see: Lopez-Antinano F.J., Schmunis G.A. Plasmodia of Humans. Parasitic Protozoa. Vol. 5:1993;146-169 Academic, New York, Oaks S.C., Mitchel V.S., Pearson G.W., Carpenter C.C.J. MALARIA: and Obstacles and Opportunities. 1991;National Academy, Washington, DC.
2. For a brief introduction, see: Lopez-Antinano F.J., Schmunis G.A. Plasmodia of Humans. Parasitic Protozoa. Vol. 5:1993;146-169 Academic, New York, Oaks S.C., Mitchel V.S., Pearson G.W., Carpenter C.C.J. MALARIA: and Obstacles and Opportunities. 1991;National Academy, Washington, DC.
3. Martin P.H., Lefebvre M.G. Ambio. 24:1998;200-209 See, for example: The New York Times, January 8, 1997, p 1; The Wall Street Journal, May 7, 2001, p B12; The Globe and Mail, June 18, 1977, p 1; Business Week, September 21, 1998, p 70; The Ottawa Citizen, September 28, 1997, p A3 . See, for example: Miller L.H., Good M.F., Milon G. Science. 264:1994;1883-1898.
4. Martin P.H., Lefebvre M.G. Ambio. 24:1998;200-209 See, for example: The New York Times, January 8, 1997, p 1; The Wall Street Journal, May 7, 2001, p B12; The Globe and Mail, June 18, 1977, p 1; Business Week, September 21, 1998, p 70; The Ottawa Citizen, September 28, 1997, p A3 . See, for example: Miller L.H., Good M.F., Milon G. Science. 264:1994;1883-1898.
5. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K., Eisen J.A., Rutherford K., Salzberg S.L., Craig A., Kyes S., Chan M.-S., Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M., Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M.A., Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFaddeb G.I., Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J., Hoffmann S.L., Newbold C., Davis R.W., Fraser C.M., Barrel B. Nature. 419:2002;498-511.
6. Schofield L., Hewitt M.C., Evans K., Slomos M.-A., Seeberger P. Nature. 418:2002;785-789 Travis J. Sci. News. 162:2002;99 Pasvol G. Trends Parasitol. 18:2002;524-525 Stoute J.H., Slaoui M., Heppiner D.G., Momir P., Kester K.E., Desmons P., Wellde B.T., Gareon N., Krzych U., Marchand M., Ballou W.R., Cohen J.D. New Engl. J. Med. 336:1997;86-91 Simmis P., Nussenzweg V. Hoffman S.L. Malaria Vaccine Development: A Multi-immune Response Approach. 1996;15-33 ASM, Washington, DC.
7. Schofield L., Hewitt M.C., Evans K., Slomos M.-A., Seeberger P. Nature. 418:2002;785-789 Travis J. Sci. News. 162:2002;99 Pasvol G. Trends Parasitol. 18:2002;524-525 Stoute J.H., Slaoui M., Heppiner D.G., Momir P., Kester K.E., Desmons P., Wellde B.T., Gareon N., Krzych U., Marchand M., Ballou W.R., Cohen J.D. New Engl. J. Med. 336:1997;86-91 Simmis P., Nussenzweg V. Hoffman S.L. Malaria Vaccine Development: A Multi-immune Response Approach. 1996;15-33 ASM, Washington, DC.
8. Schofield L., Hewitt M.C., Evans K., Slomos M.-A., Seeberger P. Nature. 418:2002;785-789 Travis J. Sci. News. 162:2002;99 Pasvol G. Trends Parasitol. 18:2002;524-525 Stoute J.H., Slaoui M., Heppiner D.G., Momir P., Kester K.E., Desmons P., Wellde B.T., Gareon N., Krzych U., Marchand M., Ballou W.R., Cohen J.D. New Engl. J. Med. 336:1997;86-91 Simmis P., Nussenzweg V. Hoffman S.L. Malaria Vaccine Development: A Multi-immune Response Approach. 1996;15-33 ASM, Washington, DC.
9. Schofield L., Hewitt M.C., Evans K., Slomos M.-A., Seeberger P. Nature. 418:2002;785-789 Travis J. Sci. News. 162:2002;99 Pasvol G. Trends Parasitol. 18:2002;524-525 Stoute J.H., Slaoui M., Heppiner D.G., Momir P., Kester K.E., Desmons P., Wellde B.T., Gareon N., Krzych U., Marchand M., Ballou W.R., Cohen J.D. New Engl. J. Med. 336:1997;86-91 Simmis P., Nussenzweg V. Hoffman S.L. Malaria Vaccine Development: A Multi-immune Response Approach. 1996;15-33 ASM, Washington, DC.
10. Schofield L., Hewitt M.C., Evans K., Slomos M.-A., Seeberger P. Nature. 418:2002;785-789 Travis J. Sci. News. 162:2002;99 Pasvol G. Trends Parasitol. 18:2002;524-525 Stoute J.H., Slaoui M., Heppiner D.G., Momir P., Kester K.E., Desmons P., Wellde B.T., Gareon N., Krzych U., Marchand M., Ballou W.R., Cohen J.D. New Engl. J. Med. 336:1997;86-91 Simmis P., Nussenzweg V. Hoffman S.L. Malaria Vaccine Development: A Multi-immune Response Approach. 1996;15-33 ASM, Washington, DC.
11. Bate C.A.W., Taverne J., Playfair J.H.L. Infect. Immun. 60: 1992;1894-1901 (5) Bate C.A.W., Taverne J., Bootsma H.J., Mason StH R.C., Skalko N., Gregoriadidis G., Playfair J.H.L. Immunology. 76:1992;35-41.
12. Bate C.A.W., Taverne J., Playfair J.H.L. Infect. Immun. 60: 1992;1894-1901 (5) Bate C.A.W., Taverne J., Bootsma H.J., Mason StH R.C., Skalko N., Gregoriadidis G., Playfair J.H.L. Immunology. 76:1992;35-41.
13. Schofield L., Hackett F. J. Exp. Med. 177:1993;145-153 Kristensen G., Jokobsen P.H. Exp. Parasitol. 82:1996;147-154 Caro H.N., Sheikh N.A., Taverne J., Playfair J.H.L., Rademacher T.W. Infect. Immun. 64:1996;3438-3441.
14. Schofield L., Hackett F. J. Exp. Med. 177:1993;145-153 Kristensen G., Jokobsen P.H. Exp. Parasitol. 82:1996;147-154 Caro H.N., Sheikh N.A., Taverne J., Playfair J.H.L., Rademacher T.W. Infect. Immun. 64:1996;3438-3441.
15. Schofield L., Hackett F. J. Exp. Med. 177:1993;145-153 Kristensen G., Jokobsen P.H. Exp. Parasitol. 82:1996;147-154 Caro H.N., Sheikh N.A., Taverne J., Playfair J.H.L., Rademacher T.W. Infect. Immun. 64:1996;3438-3441.
16. Gerold P., Diekmann-Schuppert G.P., Schwarz R.T. J. Biol. Chem. 269:1994;2597-2606 Gerold P., Scholfield L., Blackman M.J., Holder A.A., Schwarz R.T. Mol. Biochem. Parasitol. 75:1996;131-143.
17. Gerold P., Diekmann-Schuppert G.P., Schwarz R.T. J. Biol. Chem. 269:1994;2597-2606 Gerold P., Scholfield L., Blackman M.J., Holder A.A., Schwarz R.T. Mol. Biochem. Parasitol. 75:1996;131-143.
18. Gowda D.C. Microbes Infect. 4:2002;983-990 Naik R.S., Branch O.H., Woods A.S., Vijaykumar M., Perkins D.J., Nahlen B.L., Lal A.A., Cotter R.J., Costello C.E., Ockenhouse C.F., Davidson E.A., Gowda D.C. J. Exp. Med. 192:2000;1563-1575.
19. Gowda D.C. Microbes Infect. 4:2002;983-990 Naik R.S., Branch O.H., Woods A.S., Vijaykumar M., Perkins D.J., Nahlen B.L., Lal A.A., Cotter R.J., Costello C.E., Ockenhouse C.F., Davidson E.A., Gowda D.C. J. Exp. Med. 192:2000;1563-1575.
20. Güther M.L.S., Ferguson M.A.J. EMBO J. 14:1995;3080-3093.
21. Kinoshita T., Inoue N. Curr. Opin. Chem. Biol. 4:2000;632-638.
22. Ferguson M.A.J. J. Cell. Sci. 112:1999;2799-2809.
23. Maeda Y., Watanabe R., Harris C.L., Hong Y., Ohishi K., Kinoshita K., Kinoshita T. EMBO J. 20:2001;250-261.
24. Treumann A., Lifely M.R., Schneider P., Ferguson M.A.J. J. Biol. Chem. 270:1995;6088-6099.
25. Roberts W.L., Santikarn S., Reinhold V.N., Rosenberry T.L. J. Biol. Chem. 263:1988;18776-18784.
26. Campbell A.S. Fraser-Reid B., Tatsuta K., Thiem J. Glycoscience: Chemistry and Biology. Vol. 2:2001;1696-1717 Springer, Heildelberg.
27. See, for example: Pakari K., Schmidt R.R. J. Org. Chem. 68: 2003;1295-1308 Campbell A.S., Fraser-Reid B. J. Am. Chem. Soc. 117:1995;10387-10388 Baeschlin D.K., Chaperon A.R., Green L.G., Hahn M.G., Ince S.J., Ley S.V. Chem. Eur. J. 6:2000;172-186 Ogawa T. Chem. Rev. 23:1994;397.
28. See, for example: Pakari K., Schmidt R.R. J. Org. Chem. 68: 2003;1295-1308 Campbell A.S., Fraser-Reid B. J. Am. Chem. Soc. 117:1995;10387-10388 Baeschlin D.K., Chaperon A.R., Green L.G., Hahn M.G., Ince S.J., Ley S.V. Chem. Eur. J. 6:2000;172-186 Ogawa T. Chem. Rev. 23:1994;397.
29. See, for example: Pakari K., Schmidt R.R. J. Org. Chem. 68: 2003;1295-1308 Campbell A.S., Fraser-Reid B. J. Am. Chem. Soc. 117:1995;10387-10388 Baeschlin D.K., Chaperon A.R., Green L.G., Hahn M.G., Ince S.J., Ley S.V. Chem. Eur. J. 6:2000;172-186 Ogawa T. Chem. Rev. 23:1994;397.
30. See, for example: Pakari K., Schmidt R.R. J. Org. Chem. 68: 2003;1295-1308 Campbell A.S., Fraser-Reid B. J. Am. Chem. Soc. 117:1995;10387-10388 Baeschlin D.K., Chaperon A.R., Green L.G., Hahn M.G., Ince S.J., Ley S.V. Chem. Eur. J. 6:2000;172-186 Ogawa T. Chem. Rev. 23:1994;397.
31. For a recent synthesis of a GPI with the C2 acyl (but NOT the phospholipid), see: Xue J., Shao N., Guo Z. J. Org. Chem. 68:2003;4020-4029.
32. Schlueter U., Lu J., Fraser-Reid B. Org. Lett. 5:2003;255-257.
33. Angyal S.J., Tate M.E. J. Chem. Soc. 1965;6949-6955.
34. David S. Hanessian S. Preparative Carbohydrate Chemistry. 1997;67-68 Marcel Dekker, New York.
35. Bender S.L., Budhu R.J. J. Am. Chem. Soc. 113:1991;9883-9885.
36. Mach M., Schlueter U., Mathew F., Fraser-Reid B., Hazen K.C. Tetrahedron. 58:2002;7345-7354.
37. Jia Z.J., Olsson L., Fraser-Reid B. J. Chem. Soc., Perkin Trans. 1. 1998;631-632.
38. Jayaprakash K.N., Radhakrishnan K.V., Fraser-Reid B. Tetrahedron Lett. 43:2002;6955-6959.
39. Soli E.D., Manoso A.E., Patterson M.C., DeShong P., Favor D.A., Hirschmann R., Smith A.B. III J. Org. Chem. 64:1999;3171-3177.
40. Campbell A.S., Fraser-Reid B. Bioorg. Med. Chem. 2:1994;1209-1219.
41. King J.F., Allbutt A.D. Can. J. Chem. 48:1970;1754-1759.
42. 3) δ -0.49, -0.469, 0.21, 0.37, 7.48, 7.56, 7.83, 7.87. MS calcd 2985.28, found 3010.4 (M+Na).